Press release
DiGeorge Syndrome Drug Market 2020 Share Analysis By Aevi Genomic Medicine, Inc, Bausch Health, Natera, Inc, Roche Sequencing, Enzyvant, Progenity, Inc., Boehringer Ingelheim International GmbH
DiGeorge Syndrome Drug Market
Global DiGeorge syndrome drug market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of Digeorge syndrome drug market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Global DiGeorge Syndrome Drug Market is framed with bunch of Graphical Statistics, Tables and Figures, request for a sample: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-digeorge-syndrome-drug-market
Some of the major competitors currently working in the global Digeorge syndrome drug market are Aevi Genomic Medicine, Inc, Bausch Health, Natera, Inc, Roche Sequencing, Enzyvant, Progenity, Inc., Boehringer Ingelheim International GmbH, AbbVie Inc., Amgen Inc, F. Hoffmann-La Roche Ltd, Johnson & Johnson Services, Inc, Angimmune LLC, Sumitomo Dainippon Pharma Co., Ltd., CELGENE CORPORATION, CELLECTAR BIOSCIENCES, INC, eFFECTOR Therapeutics, Inc., IMV Inc, Karyopharm, Neon Therapeutics, Novartis AG and many others.
Market Definition: Global DiGeorge Syndrome Drug Market
DiGeorge syndrome is also known as 22q11.2 deletion syndrome or velocardiofacial syndrome is a rare pediatric congenital condition where children are born with absence of chromosome 22. This results to severe immunodeficiency causing poor development of several body systems. Children with DiGeorge syndrome disorders have no ability to fight against infections.
According to the article puplished in Northwestern University, it is estimated that the incident population of DiGeorge Syndrome in the United States around 500 to 750 and over 2.5 million children diagnosed yearly. These growing incidents of DiGeorge syndrome’s population worldwide and robust pipeline for development of newer therapies are the key factors for market growth.
Market Drivers
Vulnerable pediatric population of DiGeorge syndrome
Emergence of drugs for treating serious disease such as CNS disorders and cardiovascular diseases associated with DiGeorge syndrome
Increase in the rate of R&D initiatives is driving DiGeorge syndrome therapeutics market
Market Restraints
Effective treatment is either unavailable or unaffordable
Patent expiry from many companies and introduction of generic drugs of branded version is expected to restrain the growth if the market
Inadequate knowledge about DiGeorge syndrome in some developing countries
Segmentation: Global DiGeorge Syndrome Drug Market
By Therapy Type
Regenerative Medicine Advanced Therapy
Hormone Replacement Therapy
By Treatment
Medication
Vitamin D and Calcium
Surgery
Palatoplasty
Heart defects
Others
By Route of administration
Oral
Injectable
By End Users
Hospitals
Homecare
Specialty Clinics
Others
By Geography
North America
U.S.
Canada
Mexico
South America
Brazil
Argentina
Rest of South America
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Turkey
Belgium
Netherlands
Switzerland
Rest of Europe
Asia-Pacific
Japan
China
South Korea
India
Australia
Singapore
Thailand
Malaysia
Indonesia
Philippines
Rest of Asia Pacific
Middle East & Africa
South Africa
Egypt
Saudi Arabia
United Arab Emirates
Israel
Rest of Middle East & Africa
Order a Copy of This Research Report @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-digeorge-syndrome-drug-market
Key Developments in the Market:
In June 2019, Enzyvant’s drug candidate RVT-802, a tissue-based regenerative therapy received the FDA acceptance of Biologic License Application (BLA) as well as Priority Review status for the treatment of pediatric congenital athymia associated with complete DiGeorge Anomaly (cDGA), CHARGE syndrome, and FOXN1 deficiency. If approved, it will be the first drug used for the treatment of DiGeorge syndrome and turning it into a potential blockbuster commercial milestone for Enzyvant.
In September 2017, Enzyvant received Rare Pediatric Disease designation from the FDA for RVT-802, a tissue-based regenerative therapy for treatment of congenital athymia associated with complete DiGeorge Syndrome. The FDA Rare Pediatric Disease designation will enable to receive a rare pediatric disease priority review voucher upon approval of Biologic License Application (BLA).
Reasons to Purchase this Report
Current and future of global Digeorge syndrome drug market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
Regions/Countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players
Download Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-digeorge-syndrome-drug-market
Contact:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: Corporatesales@databridgemarketresearch.com
About Data Bridge Market Research
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release DiGeorge Syndrome Drug Market 2020 Share Analysis By Aevi Genomic Medicine, Inc, Bausch Health, Natera, Inc, Roche Sequencing, Enzyvant, Progenity, Inc., Boehringer Ingelheim International GmbH here
News-ID: 2181851 • Views: …
More Releases from Data Bridge Market Research
Water Treatment System Market: Sustaining the Future of Clean Water
Introduction
Understanding Water Treatment Systems
Water treatment systems are designed to purify and disinfect water for various uses-drinking, industrial processes, irrigation, and wastewater reuse. These systems eliminate contaminants such as bacteria, viruses, heavy metals, chemicals, and particulates, making water safe and sustainable for consumption and use.
Importance in Global Sustainability
Clean water is essential to life and industrial progress. With growing water demand and pollution, water treatment systems are now critical infrastructure across the…
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032.
With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal…
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032.
With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal…
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032.
With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal…
More Releases for DiGeorge
DiGeorge Syndrome Drug Market by Product, End User, Type, and Mode, Worldwide Fo …
Data Bridge Market Research analyses that the Digeorge Syndrome Drug Market will exhibit a CAGR of around 4.70% for the forecast period of 2028. Growing incidence of DiGeorge syndrome's population and development of newer therapies and treatment are the major factors attributable to the growth of DiGeorge syndrome drug market.
Industry Analysis
DiGeorge syndrome is a chromosomal disorder caused by the defect in chromosome 22. DiGeorge syndrome leads to poor development of…
Global DiGeorge Syndrome Drug Market Report Forecast to 2021-2027 |key players a …
The chromosome 22 abnormality causes DiGeorge syndrome, which is a chromosomal condition. DiGeorge syndrome causes delays in the development of various body systems, as well as cardiac problems, impaired immunological function, a cleft palate, and low calcium levels in the blood.
Clinics, patients, and other clinical benefits are available to enterprises associated with the DiGeorge Syndrome Drug Market industry. These organizations that provide clinical protection have become necessary and chosen support…
DiGeorge Syndrome Drug Market Share, Trends, Future Scope, Forecast 2026| Aevi G …
The in-depth research report on DiGeorge Syndrome Drug Market added to its huge repository by DBMR provides imprehensive and all aspects of market research. The market insights of this market report helps with the successful launch of new product. The report efficiently gathers, analyzes and interprets information about a market, about a product or service to be offered for sale in that market. Potential customers for the product or service and…
DiGeorge Syndrome Drug Market 2020 Size, Share and Trend Analysis | Top Vendors …
The DiGeorge Syndrome Drug Market report lists and studies the leading competitors, as well as provides the insights with strategic industry analysis of the key factors influencing the market dynamics. In this report, the market is segmented according to type, application, end users, and region. Moreover, it presents granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. Each segment and sub-segment is studied carefully…
DiGeorge Syndrome Drug Market 2020 Future Outlook | Key Players - Aevi Genomic M …
The primary sources employed while generating this DiGeorge Syndrome Drug Market report include the industry experts from the industry comprising the management corporation, processing organizations, analytical service suppliers of the industry's value chain. All primary sources are interviewed to accumulate the data and validate qualitative & quantitative information and conclude future prospects. Secondary research consists of key data about the industry value chain, the complete pool of major players, and…
DiGeorge Syndrome Drug Market Worth Observing Growth : CELLECTAR BIOSCIENCES, IN …
The DiGeorge Syndrome Drug Market analysis report brings into focus studies about market definition, market segmentation, and competitive analysis in the market. The precise and state-of-the-art information provided via this report helps businesses get aware about the types of consumers, consumer's demands and preferences, their point of view about the product, their buying intentions, their response to particular product, and their varying tastes about the specific product already existing in…
